|
MechanismCD160 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCD160 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismFerritin inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with MABLife SAS
0 Patents (Medical) associated with MABLife SAS
100 Deals associated with MABLife SAS
100 Translational Medicine associated with MABLife SAS